Prescription charge rises to £9.35 from 1st April

Prescription charge rises to £9.35 from 1st April

February 24, 2021

In England, the NHS prescription charge will increase to £9.35 per prescription item from 1st April 2021.

Amendments to the National Health Service (Charges for Drugs and Appliances) Regulations have been laid before Parliament which will introduce changes for both the NHS prescription charge and prescription pre-payment certificates (PPCs).

The price of a three-month PPC will become £30.25 (an increase of 60 pence) and a 12-month PPC will be £108.10 (an increase of £2.20). PPCs offer savings for those needing four or more items in three months, or 12 or more items in a year.

Prescription charge type Current charge (up to 31st March 2021) New charge (1st April 2021 onwards)
Single charge (per prescription item) £9.15 £9.35
3-month PPC £29.65 £30.25
12-month PPC £105.90 £108.10

We are in the process of updating the Prescription Charge Card for 2021/22 which will soon be available to download and print from PSNC’s website.

PSNC Chief Executive Simon Dukes said:

“The prescription charge increase is our yearly reminder that the Government mandates community pharmacy teams to be not only clinicians but also tax collectors. After the year that pharmacy teams have all experienced, the continued use of front-line healthcare staff for this purpose is unwelcome and inappropriate. It is ironic that the Exchequer is keen to use the high street pharmacy network to collect its prescription tax, yet unwilling to reimburse them their COVID-related costs in keeping pharmacy doors open in order to dispense the medicines in the first place. The Government urgently needs to find an alternative solution to the use of community pharmacy for this purpose.”


Posted in: , , ,

More Latest News >

PQS: AMS virtual event now on-demand

Community pharmacy contractors can now access an online recording of the antimicrobial stewardship (AMS) virtual event, which was jointly hosted...

Evaluation of LFD tests

As part of meeting Medicines and Healthcare products Regulatory Agency (MHRA) obligations, the UK Health Security Agency (UKHSA) – of...